Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

84.52
+0.96001.15%
Volume:458.26K
Turnover:38.79M
Market Cap:49.05B
PE:46.19
High:85.13
Open:83.65
Low:83.52
Close:83.56
52wk High:87.89
52wk Low:65.94
Shares:580.30M
Float Shares:574.00M
Volume Ratio:0.66
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.83
EPS(LYR):1.83
ROE:10.35%
ROA:7.65%
PB:4.74
PE(LYR):46.11

Loading ...

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 29

Edwards Lifesciences (EW) Gets a Buy from Jefferies

TIPRANKS
·
Jan 23

EW Scripps Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Jan 22

Leerink Partners Adjusts Edwards Lifesciences Price Target to $88 From $87, Maintains Market Perform Rating

MT Newswires Live
·
Jan 22

Venus Medtech Flags U.S. Patent Suit Over Heart Valve Technology Targeting Edwards Lifesciences

TIPRANKS
·
Jan 22

Venus MedTech Faces Patent Infringement Lawsuit Over Heart Valve Technology

Reuters
·
Jan 22

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 22

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jan 21

Stifel Adjusts Price Target on Edwards Lifesciences to $110 From $105, Maintains Buy Rating

MT Newswires Live
·
Jan 20

Edwards Lifesciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 20

Edwards Lifesciences price target raised to $98 from $95 at Piper Sandler

TIPRANKS
·
Jan 20

Edwards Lifesciences Corp : Stifel Raises Target Price to $110 From $105

THOMSON REUTERS
·
Jan 20

U.S. RESEARCH ROUNDUP-Alphabet, Micron Technology, Microsoft

Reuters
·
Jan 20

Bernstein Remains a Hold on Edwards Lifesciences (EW)

TIPRANKS
·
Jan 20

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 16

Citi Sticks to Its Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Jan 13

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jan 13

Edwards Lifesciences Is Maintained at Overweight by Barclays

Dow Jones
·
Jan 13

Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve

Benzinga_recent_news
·
Jan 12

Edwards Lifesciences price target raised to $95 from $92 at UBS

TIPRANKS
·
Jan 12